Bank of New York Mellon Corp - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 132 filers reported holding AMNEAL PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,904,888
+49.1%
688,362
+9.6%
0.00%
Q2 2023$1,947,848
+202.5%
628,338
+35.7%
0.00%
Q1 2023$643,849
-33.6%
463,201
-5.0%
0.00%
Q4 2022$969,852
-18.4%
487,363
-17.1%
0.00%
Q3 2022$1,188,000
-30.7%
587,856
+9.0%
0.00%
Q2 2022$1,715,000
-27.4%
539,330
-4.8%
0.00%
Q1 2022$2,361,000
-12.0%
566,337
+1.1%
0.00%
Q4 2021$2,684,000
-14.1%
560,240
-4.2%
0.00%
-100.0%
Q3 2021$3,123,000
+10.1%
584,843
+5.6%
0.00%0.0%
Q2 2021$2,836,000
-34.1%
553,748
-13.4%
0.00%0.0%
Q1 2021$4,304,000
+21.5%
639,543
-17.5%
0.00%0.0%
Q4 2020$3,541,000
-8.6%
774,820
-22.4%
0.00%0.0%
Q3 2020$3,873,000
-22.7%
998,046
-5.2%
0.00%0.0%
Q2 2020$5,011,000
+14.9%
1,052,772
-16.0%
0.00%0.0%
Q1 2020$4,360,000
-31.6%
1,253,009
-5.2%
0.00%
-50.0%
Q4 2019$6,374,000
+310.7%
1,322,416
+147.1%
0.00%
Q3 2019$1,552,000
-56.8%
535,250
+6.7%
0.00%
-100.0%
Q2 2019$3,595,000
-47.8%
501,408
+3.2%
0.00%
-50.0%
Q1 2019$6,887,000
+15.5%
485,973
+10.2%
0.00%0.0%
Q4 2018$5,964,000
-45.6%
440,799
-10.9%
0.00%
-33.3%
Q3 2018$10,973,000
+43.1%
494,535
+5.8%
0.00%
+50.0%
Q2 2018$7,668,000467,3290.00%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$144,839,00011.40%
Eversept Partners, LP 4,755,480$32,004,3802.41%
TPG Group Holdings (SBS) Advisors, Inc. 16,213,367$109,116,0001.27%
EAM Global Investors LLC 365,719$2,461,0000.68%
Signature Wealth Management Partners, LLC 87,666$590,0000.57%
Jackson Creek Investment Advisors LLC 221,043$1,488,0000.52%
Tranquilli Financial Advisor LLC 71,414$481,0000.39%
Hillsdale Investment Management Inc. 611,200$4,113,0000.34%
EAM Investors, LLC 259,873$1,749,0000.26%
HUSSMAN STRATEGIC ADVISORS, INC. 180,000$1,211,0000.25%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders